| Literature DB >> 34498177 |
Suranjana Mukherjee1, Sanjukta Dasgupta2, Pradyumna K Mishra3, Koel Chaudhury2.
Abstract
Air pollution is a serious threat to our health and has become one of the major causes of many diseases including cardiovascular disease, respiratory disease, and cancer. The association between air pollution and various diseases has long been a topic of research interest. However, it remains unclear how air pollution actually impacts health by modulating several important cellular functions. Recently, some evidence has emerged about air pollution-induced epigenetic changes, which are linked with the etiology of various human diseases. Among several epigenetic modifications, DNA methylation represents the most prominent epigenetic alteration underlying the air pollution-induced pathogenic mechanism. Several other types of epigenetic changes, such as histone modifications, miRNA, and non-coding RNA expression, have also been found to have been linked with air pollution. Hypersensitivity pneumonitis (HP), one of the most prevalent forms of interstitial lung diseases (ILDs), is triggered by the inhalation of certain organic and inorganic substances. HP is characterized by inflammation in the tissues around the lungs' airways and may lead to irreversible lung scarring over time. This review, in addition to other diseases, attempts to understand whether certain pollutants influence HP development through such epigenetic modifications.Entities:
Keywords: Air pollution; Epigenetic biomarkers; Epigenetic modifications; Hypersensitivity pneumonitis; Particulate matter
Mesh:
Substances:
Year: 2021 PMID: 34498177 PMCID: PMC8425320 DOI: 10.1007/s11356-021-16056-x
Source DB: PubMed Journal: Environ Sci Pollut Res Int ISSN: 0944-1344 Impact factor: 4.223
Diverse disease risks due to air pollution-mediated epigenetic changes
| Air pollutants | Epigenetic mark | Diseases/Symptoms | References | |
|---|---|---|---|---|
| 1 | PM2.5 | Promoter methylation of the tumor suppressor p16 gene | Lung cancer | Soberanes et al. |
| 2 | PM2.5 | SOX2 promoter hypermethylation | Lung Cancer | Tantoh et al. |
| 3 | PM2.5 | miRNA mediated deregulation in gene expression . | Lung Cancer | Ning et al. |
| 4 | PM2.5 | H3K27ac (histone 3 lysine 27 acetylation) | Inflammatory responses | Liu et al. |
| 5 | PM2.5 | Alterations in LINE-1 methylation, methylation at CpG loci of TNF-α | Inflammation | Wang et al. |
| 6 | PM2.5 | Altered global DNA methylation, P16 gene promoter methylation, and DNMT activity, altered post-translational histone modification. | COPD | Leclercq et al. |
| 7 | PM2.5 | Mitochondrial DNA methylation | Heart rate variability | Byun et al. |
| 8 | PM2.5 | miRNA | Cardiovascular diseases | Chen et al. |
| 9 | PM 2.5 | Methylation at candidate CpGs in monocytes | Atherosclerosis | Chi et al. |
| 10 | PM 2.5 | Genome-wide DNA methylation | Cardiometabolic diseases | Li et al. |
| 11 | PM 2.5 | ICAM-1 promoter methylation | Glucose dysregulation | Peng et al. |
| 12 | PM2.5 | Regulation of extracellular vesicle-enriched miRNA (evmiRNAs) expression by DNA methylation | Altered systolic blood pressure | Rodosthenous et al. |
| 13 | PM2.5 | Altered methylation in clock genes (CRY1, CRY2, NPAS2 ) | Ischemic stroke | Cantone et al. |
| 14 | Prenatal exposure to PM2.5 | Cord blood DNA methylation of IGF2/H19 gene | Disease risk in later life | Wang et al. |
| 15 | Prenatal exposure to PM2.5 | Lower expression levels of the miR-17/92 cluster in cord blood | Cancer risk, disease predisposition in later life | Tsamou et al. |
| 16 | PM2.5, metals from traffic sources (Cd, Fe, Mn, and Ni) | DNA methylation in imprinted control regions(L3MBTL1 | Risk associated with non-small cell lung cancer, glioma, and bladder cancer | Liang et al. |
| 17 | PM2.5 and PM10 | Hypomethylation of tandem repeats | Inflammation | Guo et al. |
| 18 | Ambient air pollutant: PM2.5, PM10, PAH, O3 | Hypermethylation of Foxp3 locus | Asthma | Janssen et al. |
| 19 | PM2.5, NOx | CpG-methylation, DMRs in circulating monocytes | Atherosclerosis pathogenesis | C Chi et al. |
| 20 | PM2.5, NO2 | DNA methylation on cytosine-phosphate-guanine (CpG) sites and differentially methylated regions (DMRs). | Inflammation and immune responses | Eze et al. |
| 21 | Traffic-related air pollution (TRAP) – PM2.5, PM10, NO2 and SO2 | DNA methylation and histone H3K9 acetylation | Respiratory disorders | Ding et al. |
| 22 | Exposure to PM2.5, PM10 during pregnancy | DNA methylation on CpG sites and on differentially methylated regions (DMRs) | Respiratory health | Gruzieva et al. |
| 23 | Ambient air pollutants: PM2.5, PM10, SO2, NO2, CO. | Genome-wide analysis of differential DNA methylation | Pulmonary disorders and cancers | Wang et al. |
| 24 | Traffic-related pollutants: PM2.5, black carbon, NO2, CO | LINE-1, Alu, and gene-specific DNA methylation tissue factor (F3), Toll-Like Receptor 2 (TLR-2), and ICAM-1) | Cardiovascular disease | Lisanti et al. |
| 25 | Prenatal exposures to PM2.5, PM10 | Altered DNA methylation in specific gene promoters | Childhood cardio-respiratory health | Breton et al. |
| 26 | Prenatal exposures to PM2.5, PM10 | Placental global DNA methylation | Placental adaptation at the level of global DNA methylation | Maghbooli et al. |
| 27 | PM10 | microRNA-101 | Blood pressure | Motta et al. |
| 28 | PM10 (most abundant elements: Al, Fe, water soluble organic fraction) | Alterations in DNA methylation in macrophages | Inflammation | Miousse et al. |
| 29 | Iron-rich combustion- and friction-derived nanoparticles (CFDNPs) that are abundantly present in airborne particulate matter | Lower H3K9me2/me3 and higher γ-H2A.X | Alzheimer's disease (AD) | Calderón-Garcidueñas et al. |
| 30 | Airborne PM and PM metallic components | Extracellular vesicle (EV) miRNAs | Inflammation and coagulation | Pavanello et al. |
| 31 | Ambient ultrafine particles (UFP, diameter Dp < 0.18 μm) | Noncoding RNAs | Neurodevelopmental and neurodegenerative disorders | Solaimani et al. |
| 32 | Ozone (O3) | miRNAs, namely miR-132, miR-143, miR-145, miR-199a*, miR-199b-5p, miR-222, miR-223, miR-25, miR-424, and miR-582-5p | Inflammatory diseases | Fry et al. |
| 33 | Ozone (O3) | DNA methylation of the apelin gene | Pulmonary edema | Miller et al. |
| 34 | Traffic-related air pollution (TRAP) | Nasal DNA methylation | Childhood asthma | Zhang et al. |
| 35 | Traffic-related air pollution | Differentially methylated CpG positions (DMPs) and differentially methylated regions (DMRs) | Asthma severity | Zhu et al. |
| 36 | Diesel exhaust particles (DEP) from traffic and house dust mite (HDM) | Changes in 5-methyl-cytosine (5mC) and 5-hydroxy-methylcytosine (5hmC) in the regulatory regions associated with transcription factors in airway epithelial cells | Airway diseases, asthma | Zhang et al. |
| 37 | Diesel Exhaust (DE) | CpG site methylation | Allergic disease | Clifford et al. |
| 38 | Diesel Exhaust (DE) | CysLT-related gene methylation | Asthma, poor lung function | Rabinovitch et al. |
| 39 | Diesel Exhaust (DE) | CpG site methylation, DMRs in bronchial epithelial cells | Pulmonary pathologies | Cardenas et al. |
| 40 | Gestational exposure to Diesel Exhaust (DE) | DNA methylation in global regulatory regions | Cardiac hypertrophy, fibrosis and susceptibility to heart failure | Goodson et al. |
| 41 | Polycyclic aromatic hydrocarbons (PAHs) | Methylation in the FOXP3 locus | Asthma, allergic rhinitis | Hew et al. |
| 42 | PAH | Higher expression of let-7a, miR-146a-5p, and miR-155-5p and lower expression of IL-6, CXCL8, and TLR2 mRNAs | Inflammation | Li et al. |
| 43 | PAH, Nitro-PAH, PM2.5 | Promoter methylation of CDKN2A, APC, and MLH1 genes and hypomethylation of the LINE-1 | Cancer risk | Silva et al. |
| 44 | Phenanthrene (Phe) | CpG island methylation of FOXP3 | Atopic conditions | Liu et al. |
| 45 | Coke oven emissions (COE), PAHs | Hypomethylation of LINE-1 and AhRR gene | Lung cancer | Yang et al. |
| 46 | Air pollutants | Histone modifications (H3K9ac, H3K9me3, H3K27me3, and H3K36me3) | Blood pressure | Kresovich et al. |
| 47 | Air pollution | Methylenetetrahydrofolate reductase ( | Alzheimer’s disease (AD) | Wu et al. |
| 48 | Environmental tobacco smoke | Alteration in gene-specific and global DNA methylation | Allergic asthma | Christensen et al. |
| 49 | Tobacco smoke exposure | CD14 methylation | Allergic diseases | Munthe-Kaas et al. |
| 50 | Environmental tobacco smoke | Alterations in methylation pattern of IFN-γ and Thy-1 promoters | Respiratory diseases | Cole et al. |
| 51 | Prenatal exposure to tobacco smoke | Alterations in DNA methylation of LINE1 and AluYb8. Changes in the methylation on CpGs in the promoter region of AXL and PTPRO genes. | Disease risk in later life | Breton et al. |
| 52 | Cigarette smoke | Hypomethylation on the glutamate-cysteine ligase catalytic subunit (GCLC) gene | COPD | Cheng et al. |
| 53 | Cigarette smoke | CpG methylation Of gene AIRE, PENK and SLC6A3 | Non-small cell lung cancer | Ma et al. |
| 54 | Cigarette smoke | DNA methylation in white blood cells | Cardiovascular diseases | Chatziioannou et al. |
| 55 | Cigarette smoke | DNA methylation | Schizophrenia | Ma et al. |
| 56 | Indoor air pollution caused by smoky coals with high benzo(a)pyrene (BaP) and quartz levels | CDKN2A, DLEC1, CDH1, DAPK, RUNX3, APC, and WIF1 DNA methylation in the promoter region | Primary non-small cell lung cancer (NSCLC) | Huang et al. |
| 57 | Biomass smoke | miR-126 and miR-155 | Cardiovascular diseases | Ruiz-Vera et al. |
| 58 | Second-hand smoke | Altered methylation of major repetitive DNA elements including LINE L1, IAP LTR and SINE B1 | Lung cancer | Tommasi et al. |
| 59 | Second-hand smoke | DNA methylation of several CpG loci | Bladder carcinoma | Wilhelm-Benartzi et al. |
| 60 | Second-hand smoke | CpG methylation within FOXP3 and IFNγ loci | Asthma | Runyon et al. |
| 61 | Smoke and second-hand smoke | Altered methylation of GSTP1, FHIT, and CDKN2A, SCGB3A1 and BRCA1genes | Breast cancer | Callahan et al. |
Fig. 1Epigenetic alterations in the mammalian system. (a) DNA methylation at the DNA bases, (b) different types of modifications at the histone tails, and (c) interference of the non-coding RNAs (ncRNAs) with the gene expression process
Common HP-inducing antigens
| Name of the Disease | Origin | Antigen | Source of Antigen |
|---|---|---|---|
| 1. Farmer’s lung | Bacterial | Moldy hay | |
| 2. Summer-type HP | Fungal | Contaminated old houses | |
| 3. Hot tub lung | Mycobacterial | Mycobacterium avium complex (MAC), composed of | Contaminated water |
| 4. Bird fancier’s lung | Animal fur protein | Avian proteins | Feather bloom, avian serum(pigeons, chicken, turkey, goose, avian proteins),and excrement (mainly due to pigeon intestinal mucin) |
| 5. Chemical worker’s lung | Low-molecular weight chemicals | Diisocyanates, trimellitic anhydride | Polyurethane foams, spray paints, dyes, glues |
Fig. 2Mechanism showing HP development by increasing host susceptibility through air pollution exposure. a) Emission of industrial and traffic-related air pollution. Pollutants reach the alveolar spaces in the lungs and induce epigenetic changes in the lungs’ microenvironment, thereby influencing host susceptibility to disease development. b) The interaction between the causative antigen deposited in alveolar spaces and the circulating IgG antibody forms precipitating antigen-antibody immune complexes in interstitial spaces. Immune complexes trigger activation of both complement and pulmonary macrophages. Activated macrophages secrete the cytokines IL-1 and TNF-a that promote adhesion of leukocytes to activated endothelium. Complement activation enhances vascular permeability and attracts inflammatory cells. As a consequence of recruitment and activation, inflammatory cells release toxic mediators that promote acute lung injury, which eventually leads to HP development